Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyo sarcomas: a comparative genomic hybridization study

被引:36
作者
Hu, J
Rao, UNM
Jasani, S
Khanna, V
Yaw, K
Surti, U
机构
[1] Magee Womens Res Inst, Pittsburgh Cytogenet Lab, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA
[3] Univ Pittsburgh, Med Ctr, UPMC Shadyside, Dept Pathol, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Sch Med, Pittsburgh, PA 15260 USA
[5] UPMC Shadyside, Dept Orthoped Surg, Pittsburgh, PA USA
关键词
n;
D O I
10.1016/j.cancergencyto.2005.01.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Leiomyosarcomas (LMS) account for 10-20 % of all soft tissue sarcomas. We analyzed 10 primary, 5 metastatic, and 2 recurrent extrauterine LMS. Genomic imbalances were detected in 15 out of the 17 tumors. The most common regions of loss were 13q (59 %, 10 of 17), 10q (59 %, 10 of 17), 2q (35 %, 6 of 17), and 16q (29 %, 5 of 17). The most common region of gain was 5p (35 %, 6 of 17). High-level gain of DNA copy number was detected in 6p and 17p. Loss of function of tumor suppressor genes or the activation of oncogenes (or both of these factors) resulting from these copy number changes might play an important role in the development of extrauterine LMS. Large tumors and tumors with metastasis showed 10q deletions. Gain of 5p was detected only in G3 tumors. These findings are consistent with our earlier study on uterine LMS and indicate that loss of 10q and gain of 5p are associated with an aggressive behavior of LMS. A larger series of cases is needed to confirm these results. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 43 条
[11]   COMPARATIVE GENOMIC HYBRIDIZATION ANALYSIS OF HUMAN SARCOMAS .2. IDENTIFICATION OF NOVEL AMPLICONS AT 6P AND 17P IN OSTEOSARCOMAS [J].
FORUS, A ;
WEGHUIS, DO ;
SMEETS, D ;
FODSTAD, O ;
MYKLEBOST, O ;
VANKESSEL, AG .
GENES CHROMOSOMES & CANCER, 1995, 14 (01) :15-21
[12]   Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas [J].
Forus, A ;
Berner, JM ;
Meza-Zepeda, LA ;
Saeter, G ;
Mischke, D ;
Fodstad, O ;
Myklebost, O .
BRITISH JOURNAL OF CANCER, 1998, 78 (04) :495-503
[13]  
FU YS, 1994, PRACTICAL GYNECOLOGI, P117
[14]  
Glukhova L, 1998, GENE CHROMOSOME CANC, V22, P171, DOI 10.1002/(SICI)1098-2264(199807)22:3<171::AID-GCC2>3.0.CO
[15]  
2-T
[16]   SIMILAR CHROMOSOMAL EVOLUTION IN A UTERINE STROMOMYOSARCOMA AND IN ONE OF 2 LEIOMYOMAS FROM THE SAME PATIENT [J].
HAVEL, G ;
DAHLENFORS, R ;
WEDELL, B ;
MARK, J .
APMIS, 1989, 97 (02) :143-146
[17]   Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis [J].
Hu, J ;
Khanna, V ;
Jones, M ;
Surti, U .
GENES CHROMOSOMES & CANCER, 2001, 31 (02) :117-124
[18]   Mutational analysis of the PTEN gene in human uterine sarcomas [J].
Lancaster, JM ;
Risinger, JI ;
Carney, ME ;
Barrett, JC ;
Berchuck, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (06) :1051-1053
[19]  
LAXMAN R, 1993, CANCER, V71, P1283, DOI 10.1002/1097-0142(19930215)71:4<1283::AID-CNCR2820710419>3.0.CO
[20]  
2-I